P. James

发表

Systemic amyloidosis in Uganda. An autopsy study.

P. James, R. Owor, 1975, Transactions of the Royal Society of Tropical Medicine and Hygiene.

The Canadian "National Program for hemophilia mutation testing" database: a ten-year review.

J. Leggo, P. James, D. Lillicrap, 2013, American journal of hematology.

Von Willebrand disease.

P. James, D. Lillicrap, J. Robertson, 2008, Pediatric clinics of North America.

Discrepant platelet and plasma von Willebrand factor in von Willebrand disease patients with p.Pro2808Leufs*24

P. James, D. Lillicrap, A. Tuttle, 2017, Journal of thrombosis and haemostasis : JTH.

The C-type lectin receptor CLEC4M binds, internalizes, and clears von Willebrand factor and contributes to the variation in plasma von Willebrand factor levels.

A. Paterson, R. Montgomery, P. James, 2013, Blood.

von Willebrand disease

P. James, A. Goodeve, 2011, Genetics in Medicine.

ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders

B. Coller, A. Tosetto, P. James, 2010, Journal of thrombosis and haemostasis : JTH.

Relevance of quantitative assessment of bleeding in haemorrhagic disorders

A. Tosetto, P. James, F. Rodeghiero, 2008, Haemophilia : the official journal of the World Federation of Hemophilia.

Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States.

D. Bellissimo, R. Hoffmann, C. Leissinger, 2016, Blood.

D-lactic acidosis and ataxia in a man with Crohn disease

A. Kuper, P. James, F. Saibil, 2010, Canadian Medical Association Journal.

Severity and Features of Epistaxis in Children with a Mucocutaneous Bleeding Disorder

V. Blanchette, P. James, T. Biss, 2017, The Journal of pediatrics.

Quantitation of bleeding symptoms in children with von Willebrand disease: use of a standardized pediatric bleeding questionnaire

V. Blanchette, P. James, D. Lillicrap, 2010, Journal of thrombosis and haemostasis : JTH.

A prospective evaluation of the prevalence of symptomatic von Willebrand disease (VWD) in a pediatric primary care population

P. James, W. Hopman, D. Lillicrap, 2010, Pediatric blood & cancer.

Sexism in the management of bleeding disorders

P. James, A. Weyand, 2020, Research and practice in thrombosis and haemostasis.

Quantitative and qualitative changes of von Willebrand factor and their impact on mortality in patients with end-stage kidney disease

P. James, R. Holden, A. Tuttle, 2013, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Ringer’s lactate is compatible with the rapid infusion of AS-3 preserved packed red blood cells

P. James, J. Parlow, J. Vlymen, 2009, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

Controversies in the diagnosis of Type 1 von Willebrand disease

P. James, M. Bowman, 2017, International journal of laboratory hematology.

Aging and ABO blood type influence von Willebrand factor and factor VIII levels through interrelated mechanisms

P. James, W. Hopman, D. Lillicrap, 2016, Journal of thrombosis and haemostasis : JTH.

Using genetic diagnostics in hemophilia and von Willebrand disease.

P. James, L. Swystun, 2015, Hematology. American Society of Hematology. Education Program.

Third Åland islands conference on von Willebrand disease, 26–28 September 2012: meeting report

V. Jiménez‐Yuste, M. Morfini, M. Makris, 2013, Haemophilia : the official journal of the World Federation of Hemophilia.

The mutational spectrum of type 1 von Willebrand disease: Results from a Canadian cohort study.

L. O'Brien, J. Leggo, M. Othman, 2007, Blood.

Bleeding assessment tools in the diagnosis of VWD in adults and children: a systematic review and meta-analysis of test accuracy

R. Mustafa, J. Eikenboom, R. Montgomery, 2021, Blood advances.

Outcomes of long‐term von Willebrand factor prophylaxis use in von Willebrand disease: A systematic literature review

R. Mustafa, A. Tosetto, M. Laffan, 2022, Haemophilia : the official journal of the World Federation of Hemophilia.

An international survey to inform priorities for new guidelines on von Willebrand disease

R. Mustafa, P. James, R. Brignardello-Petersen, 2019, Haemophilia : the official journal of the World Federation of Hemophilia.

Generation and validation of the Condensed MCMDM‐1VWD Bleeding Questionnaire for von Willebrand disease

P. James, W. Hopman, D. Lillicrap, 2008, Journal of thrombosis and haemostasis : JTH.

Response to “The 2021 von Willebrand disease guidelines: Clarity and controversy”

R. Mustafa, P. James, V. Flood, 2022, Haemophilia : the official journal of the World Federation of Hemophilia.

Patients with aortic stenosis have von Willebrand factor abnormalities and increased proliferation of endothelial colony forming cells

R. Kloosterman, P. James, J. Grabell, 2019, Journal of thrombosis and haemostasis : JTH.

Relative contributions of bleeding scores and iron status on health‐related quality of life in von Willebrand disease: a cross‐sectional study

P. James, W. Hopman, J. Grabell, 2017, Haemophilia : the official journal of the World Federation of Hemophilia.

Molecular Diagnostic Approaches to Hemostasis

P. James, D. Lillicrap, 2007 .

Increased galactose expression and enhanced clearance in patients with low von Willebrand factor.

Kenneth L. Jones, P. James, J. Di Paola, 2019, Blood.

Presentation and management of acute coronary syndromes among adult persons with haemophilia: results of an international, retrospective, 10‐year survey

J. Mahlangu, P. James, P. Holme, 2015, Haemophilia : the official journal of the World Federation of Hemophilia.

Spinal Anesthesia in 2 Consecutive Cesarean Deliveries in a Parturient With Type 3 von Willebrand Disease: A Case Report.

P. James, S. Haley, J. W. Parker, 2019, A&A practice.

Significant gynecological bleeding in women with low von Willebrand factor levels.

P. James, J. Di Paola, N. O'Connell, 2018, Blood advances.

Novel insights into the clinical phenotype and pathophysiology underlying low VWF levels.

Kenneth L. Jones, P. James, J. Di Paola, 2017, Blood.

Current Management of Patients with Severe von Willebrand Disease Type 3: A 2012 Update

P. James, A. Federici, 2012, Acta Haematologica.

von Willebrand factor variant p.Arg924Gln marks an allele associated with reduced von Willebrand factor and factor VIII levels

D. Hampshire, J. Goudemand, J. Eikenboom, 2010, Journal of thrombosis and haemostasis : JTH.

Histones link inflammation and thrombosis through the induction of Weibel–Palade body exocytosis

P. Liaw, P. James, D. Lillicrap, 2016, Journal of thrombosis and haemostasis : JTH.

Vascular endothelial cells evade complement‐mediated membrane injury via Weibel‐Palade body mobilization

S. Grinstein, P. James, C. Licht, 2020, Journal of thrombosis and haemostasis : JTH.

Von Willebrand factor regulates complement on endothelial cells.

J. Atkinson, P. James, C. Licht, 2016, Kidney international.

von Willebrand disease: proposing definitions for future research.

R. Mustafa, M. Ozelo, S. O’Brien, 2021, Blood advances.

Endothelial characteristics in healthy endothelial colony forming cells; generating a robust and valid ex vivo model for vascular disease

E. Weijers, J. Eikenboom, P. James, 2020, Journal of thrombosis and haemostasis : JTH.

Surgical management of patients with von Willebrand disease: summary of 2 systematic reviews of the literature

R. Mustafa, S. O’Brien, A. Tosetto, 2021, Blood advances.

Comprehensive Evaluation of Hemostasis in Normal Women

Hisham S. Elbatarny, M. Othman, P. James, 2015, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

The diagnosis and management of von Willebrand disease in Canada.

P. James, D. Lillicrap, 2011, Seminars in thrombosis and hemostasis.

The role of molecular genetics in diagnosing von Willebrand disease.

P. James, D. Lillicrap, 2008, Seminars in thrombosis and hemostasis.

Gynecologic and obstetric management of women with von Willebrand disease: summary of 3 systematic reviews of the literature

R. Mustafa, M. Ozelo, P. James, 2021, Blood advances.

Endomyocardial fibrosis associated with daunorubicin therapy.

R. Wilcox, P. James, P. Toghill, 1976, British heart journal.

Idiopathic pulmonary arterial hypertension – a unrecognized cause of high‐shear high‐flow haemostatic defects (otherwise referred to as acquired von Willebrand syndrome) in children

M. Carcao, V. Bouskill, P. James, 2018, British journal of haematology.

Evaluation of the self‐administered bleeding assessment tool (Self‐BAT) in haemophilia carriers and correlations with quality of life

J. Mahlangu, P. James, W. Hopman, 2017, Haemophilia : the official journal of the World Federation of Hemophilia.

Management of elective procedures in low von Willebrand factor patients in the LoVIC study

P. James, J. Di Paola, A. Dougall, 2020, Journal of thrombosis and haemostasis : JTH.

Illustrated State‐of‐the‐Art Capsules of the ISTH 2020 Congress

J. Weisel, M. Ellis, D. Vaughan, 2020, Research and practice in thrombosis and haemostasis.

The genetics of Canadian type 3 von Willebrand disease: further evidence for co‐dominant inheritance of mutant alleles

V. Blanchette, J. Leggo, P. James, 2013, Journal of thrombosis and haemostasis : JTH.

Challenges in defining type 2M von Willebrand disease: results from a Canadian cohort study

P. James, D. Lillicrap, M. Poon, 2007, Journal of thrombosis and haemostasis : JTH.

The value of genetic testing for type 2B Von Willebrand disease.

P. James, D. Lillicrap, D. Rapson, 2006, Clinical and laboratory haematology.

Founder von Willebrand factor haplotype associated with type 1 von Willebrand disease.

J. Sutherland, L. O'Brien, M. Othman, 2003, Blood.

Menstruation, anticoagulation, and contraception: VTE and uterine bleeding

P. James, Bethany Samuelson Bannow, C. McLintock, 2021, Research and practice in thrombosis and haemostasis.

Obstetric bleeding among women with inherited bleeding disorders: a retrospective study

Graeme N. Smith, P. James, W. Hopman, 2016, Haemophilia : the official journal of the World Federation of Hemophilia.

The Canadian “National Program for hemophilia mutation testing” database: A ten‐year review

J. Leggo, P. James, D. Lillicrap, 2013, American journal of hematology.

Laboratory assays of VWF activity and use of desmopressin trials in the diagnosis of VWD: a systematic review and meta-analysis

R. Mustafa, B. Konkle, J. Eikenboom, 2022, Blood advances.

Abnormal angiogenesis in blood outgrowth endothelial cells derived from von Willebrand disease patients

S. Archer, P. James, D. Maurice, 2017, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Discordant von Willebrand factor (VWF) activity in patients with VWF p.Gly1324Ser confirmed in vitro

D. S. Houston, S. Israels, P. James, 2018, Haemophilia : the official journal of the World Federation of Hemophilia.

Functional characterization of a 13-bp deletion (c.-1522_-1510del13) in the promoter of the von Willebrand factor gene in type 1 von Willebrand disease.

D. Hampshire, M. Othman, A. Parker, 2010, Blood.

The effect of exercise on von Willebrand factor and ADAMTS‐13 in individuals with type 1 and type 2B von Willebrand disease

P. Lenting, P. James, D. Lillicrap, 2007, Journal of thrombosis and haemostasis : JTH.

Rare bleeding disorders – bleeding assessment tools, laboratory aspects and phenotype and therapy of FXI deficiency

P. James, F. Peyvandi, O. Salomon, 2014, Haemophilia : the official journal of the World Federation of Hemophilia.

Approach to the Diagnosis and Management of Common Bleeding Disorders

P. James, N. Rydz, Natalia Rydz, 2012, Seminars in Thrombosis & Hemostasis.

Evaluation of the diagnostic utility for von Willebrand disease of a pediatric bleeding questionnaire

A. Tosetto, P. James, M. Rand, 2009, Journal of thrombosis and haemostasis : JTH.

Acquired von Willebrand syndrome: von Willebrand factor propeptide to von Willebrand factor antigen ratio predicts remission status.

Adrienne Lee, P. James, M. Poon, 2014, Blood.

Utility of a Paediatric Bleeding Questionnaire as a screening tool for von Willebrand disease in apparently healthy children

S. Shott, L. Valentino, P. James, 2015, Haemophilia : the official journal of the World Federation of Hemophilia.

The prevalence of symptomatic von Willebrand disease in primary care practice

P. James, W. Hopman, D. Lillicrap, 2010, Journal of thrombosis and haemostasis : JTH.

To Treat or Not? Remission Induction of Acquired von Willebrand Syndrome Secondary to Chronic Lymphocytic Leukemia: A Case Report.

L. Huebsch, A. Tinmouth, P. James, 2021, Clinical lymphoma, myeloma & leukemia.

Changes in von Willebrand factor level and von Willebrand activity with age in type 1 von Willebrand disease

P. James, D. Lillicrap, J. Grabell, 2015, Haemophilia : the official journal of the World Federation of Hemophilia.

Women and bleeding disorders: diagnostic challenges.

P. James, 2020, Hematology. American Society of Hematology. Education Program.

Heavy menstrual bleeding: is tranexamic acid a safe adjunct to combined hormonal contraception?

P. James, R. Reid, J. Thorne, 2018, Contraception.

Aminoglycoside suppression of nonsense mutations in severe hemophilia.

J. Leggo, P. James, D. Lillicrap, 2005, Blood.

Genetic diagnosis in hemophilia and von Willebrand disease.

P. James, L. Swystun, 2017, Blood reviews.

Phenotyping bleeding

B. Coller, P. James, 2012, Current opinion in hematology.

Pregnancy and delivery in women with von Willebrand disease

P. James, G. Castaman, 2019, European journal of haematology.

Genetic linkage and association analysis in type 1 von Willebrand disease: results from the Canadian Type 1 VWD Study

A. Paterson, L. O'Brien, J. Leggo, 2006, Journal of thrombosis and haemostasis : JTH.

A new hemophilia carrier nomenclature to define hemophilia in women and girls: Communication from the SSC of the ISTH

M. Othman, J. Mahlangu, P. James, 2021, Journal of thrombosis and haemostasis : JTH.

Bone health in symptomatic carriers of haemophilia A: a protocol for a multicentre prospective matched-cohort study

Adrienne Lee, R. Nisenbaum, P. James, 2019, BMJ Open.

Evaluation of the utility of the ISTH‐BAT in haemophilia carriers: a multinational study

J. Mahlangu, P. James, W. Hopman, 2016, Haemophilia : the official journal of the World Federation of Hemophilia.

A decreased and less sustained desmopressin response in hemophilia A carriers contributes to bleeding.

P. James, W. Hopman, R. Sidonio, 2018, Blood advances.

Switching to nonacog beta pegol in hemophilia B: Outcomes from a Canadian real‐world, multicenter, retrospective study

A. Iorio, E. Iserman, F. Germini, 2022, Research and practice in thrombosis and haemostasis.

von Willebrand Disease: a Report from a Meeting in the Åland Islands 2012 Summary of a Nordic Symposium on von Willebrand Disease, 26–28 September 2012, Mariehamn, Åland, Finland

V. Jiménez‐Yuste, M. Morfini, M. Makris, 2013 .

The evolution and value of bleeding assessment tools

P. James, N. Rydz, Natalia Rydz, 2012, Journal of thrombosis and haemostasis : JTH.

Special considerations in GI bleeding in VWD patients.

P. James, N. L. Chornenki, Edwin Ocran, 2022, Hematology. American Society of Hematology. Education Program.

ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease.

R. Mustafa, M. Ozelo, S. O’Brien, 2021, Blood advances.

Angiodysplasia in von Willebrand Disease: Understanding the Clinical and Basic Science

P. James, Soundarya N Selvam, 2017, Seminars in Thrombosis and Hemostasis.

Alloantibodies in von Willebrand disease.

P. Mannucci, P. James, D. Lillicrap, 2013, Blood.

Bleeding Scores for the Diagnosis of von Willebrand Disease

P. James, M. Bowman, 2017, Seminars in Thrombosis and Hemostasis.

Clinical Aspects of von Willebrand Disease: Bleeding History

A. Tosetto, P. James, 2011 .

Quantitative assessment of bleeding in haemorrhagic disorders : the case of menorrhagia

A. Tosetto, P. James, F. Rodeghiero, 2008 .

Vascular abnormalities in patients with von Willebrand disease: A scoping review

P. James, Maaz Shanjer, N. L. Chornenki, 2021, Journal of thrombosis and haemostasis : JTH.

Malposition and expulsion of the levonorgestrel intrauterine system among women with inherited bleeding disorders

P. James, M. Jamieson, E. Rimmer, 2013, Haemophilia : the official journal of the World Federation of Hemophilia.

Utility of factor VIII and factor VIII to von Willebrand factor ratio in identifying 277 unselected carriers of hemophilia A

V. Blanchette, M. Carcao, V. Bouskill, 2017, American journal of hematology.

Use of a quantitative pediatric bleeding questionnaire to assess mucocutaneous bleeding symptoms in children with a platelet function disorder

V. Blanchette, P. James, T. Biss, 2010, Journal of thrombosis and haemostasis : JTH.

The genetics of Canadian type 3 von Willebrand disease: further evidence for codominant inheritance of mutant alleles: a reply to a rebuttal

P. James, D. Lillicrap, M. Bowman, 2013, Journal of thrombosis and haemostasis : JTH.

The molecular characterization of von Willebrand disease: good in parts

P. James, D. Lillicrap, David Lillicrap, 2013, British journal of haematology.

ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease.

R. Mustafa, B. Konkle, J. Eikenboom, 2021, Blood advances.

Let's Talk Period! Preliminary results of an online bleeding awareness knowledge translation project and bleeding assessment tool promoted on social media

P. James, J. Grabell, E. Reynen, 2017, Haemophilia : the official journal of the World Federation of Hemophilia.

Generation and optimization of the self‐administered bleeding assessment tool and its validation as a screening test for von Willebrand disease

P. James, W. Hopman, A. Tuttle, 2013, Haemophilia : the official journal of the World Federation of Hemophilia.

Why is my patient bleeding or bruising?

P. James, N. Rydz, Natalia Rydz, 2012, Hematology/oncology clinics of North America.

VON WILLEBRAND DISEASE: AN INTRODUCTION FOR THE PRIMARY CARE PHYSICIAN

P. James, D. Lillicrap, 2009 .

Normal range of bleeding scores for the ISTH‐BAT: adult and pediatric data from the merging project

Shamim A. Mollah, B. Coller, R. Montgomery, 2014, Haemophilia : the official journal of the World Federation of Hemophilia.

Systematic Analysis of Bleeding Phenotype in PT-VWD Compared to Type 2B VWD Using an Electronic Bleeding Questionnaire

M. Ozelo, M. Othman, P. James, 2014, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

An assessment of the pathogenic significance of the R924Q von Willebrand factor substitution

P. James, D. Lillicrap, C. Hough, 2009, Journal of thrombosis and haemostasis : JTH.

Bleeding assessment tools to predict von Willebrand disease: Utility of individual bleeding symptoms

A. Paterson, Yupu Liang, B. Coller, 2019, Research and practice in thrombosis and haemostasis.

Generation and optimization of the self‐administered pediatric bleeding questionnaire and its validation as a screening tool for von Willebrand disease

V. Blanchette, P. Moorehead, R. Klaassen, 2017, Pediatric blood & cancer.

von Willebrand disease: Clinical and laboratory lessons learned from the large von Willebrand disease studies

P. James, D. Lillicrap, 2012, American journal of hematology.

Genetic testing for von Willebrand disease: the Canadian experience.

P. James, D. Lillicrap, 2006, Seminars in thrombosis and hemostasis.

Approach to the Patient with Bleeding.

P. James, Megan Chaigneau, 2021, Hematology/oncology clinics of North America.

The endothelial lectin clearance receptor CLEC4M binds and internalizes factor VIII in a VWF‐dependent and independent manner

P. James, D. Lillicrap, J. Lai, 2019, Journal of thrombosis and haemostasis : JTH.

Relationship between diagnosis and intervention in women with inherited bleeding disorders and menorrhagia

P. James, S. Sanders, M. Silva, 2012, Haemophilia : the official journal of the World Federation of Hemophilia.

An inter-observer and intra-observer variability study on the diagnosis of lymph node biopsy specimens.

W. Gregory, P. Hall, D. Levison, 1992, European journal of cancer.

Ringer’s lactate is compatible with saline-adenine-glucose-mannitol preserved packed red blood cells for rapid transfusion

P. James, A. Tuttle, J. Parlow, 2010, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial

Marcelo A. Falappa, Tariq M. Alhawassi, A. Laupacis, 2021, BMJ.

Endothelial BMPR2 Loss Drives a Proliferative Response to BMP (Bone Morphogenetic Protein) 9 via Prolonged Canonical Signaling

S. Archer, P. James, D. Maurice, 2020, Arteriosclerosis, thrombosis, and vascular biology.

Von Willebrand Disease and Pregnancy: A Review of Evidence and Expert Opinion

P. James, E. Reynen, Emily Reynen, 2016, Seminars in Thrombosis and Hemostasis.

Acquired von Willebrand syndrome in paediatric patients with congenital heart disease: challenges in the diagnosis and management of this rare condition

V. Bouskill, P. James, M. L. Avila, 2015, Haemophilia : the official journal of the World Federation of Hemophilia.

A novel type 2A von Willebrand factor mutation located at the last nucleotide of exon 26 (3538G>A) causes skipping of 2 nonadjacent exons.

L. O'Brien, P. James, D. Lillicrap, 2004, Blood.

VWD diagnosis: improved.

P. James, 2016, Blood.

CANADIAN ASSOCIATION OF NURSES IN HEMOPHILIA CARE The Canadian Association of Nurses in Hemophilia Care

P. James, D. Lillicrap, 2011 .

Randomized trials of therapeutic heparin for COVID‐19: A meta‐analysis

K. Thorpe, S. Middeldorp, B. D. da Costa, 2021, Research and Practice in Thrombosis and Haemostasis.

von Willebrand factor levels in the diagnosis of von Willebrand disease: a systematic review and meta-analysis

R. Mustafa, J. Eikenboom, R. Montgomery, 2021, Blood advances.

The Endothelial Lectin Receptor CLEC4M Internalizes Factor VIII and Von Willebrand Factor Via a Clathrin-Coated Pit-Dependent Mechanism

P. James, D. Lillicrap, C. Notley, 2013 .

Sequence Variation in Vitamin K Epoxide Reductase Gene Is Associated With Survival and Progressive Coronary Calcification in Chronic Kidney Disease

S. Booth, A. R. Morton, P. James, 2014, Arteriosclerosis, Thrombosis and Vascular Biology.

Characterization of aberrant splicing of von Willebrand factor in von Willebrand disease: an underrecognized mechanism.

P. James, M. Poon, G. Rivard, 2016, Blood.

The endothelial cell receptor stabilin-2 regulates VWF-FVIII complex half-life and immunogenicity

S. Goerdt, R. Montgomery, P. James, 2018, The Journal of clinical investigation.

Longitudinal bleeding assessment in von Willebrand disease utilizing an interim bleeding score

R. Montgomery, P. Christopherson, P. James, 2022, Journal of thrombosis and haemostasis : JTH.

Evaluating the effectiveness of let’s talk period’s high school educational outreach program: A pilot study

P. James, W. Hopman, Lisa Thibeault, 2021, Haemophilia.

Validation of the school age self‐administered pediatric bleeding questionnaire (Self‐PBQ) in children aged 8–12 years

V. Blanchette, N. Barrowman, R. Klaassen, 2019, Pediatric blood & cancer.

Bleeding Assessment Tools

P. James, 2013, Inherited Bleeding Disorders in Women 2e.

A Population-Based Cohort Study of Venous Thromboembolism Rates Following Surgery and During Adjuvant Chemotherapy in Patients With Colon Cancer

C. Booth, P. James, Sunil V. Patel, 2020, Diseases of the colon and rectum.

Expanded phenotype–genotype correlations in a pediatric population with type 1 von Willebrand disease

V. Blanchette, M. Carcao, P. James, 2011, Journal of thrombosis and haemostasis : JTH.

Von Willebrand disease: Gaining a global perspective.

J. Stonebraker, M. Makris, P. James, 2023, Haemophilia : the official journal of the World Federation of Hemophilia.

Desmopressin responsiveness by age in type 1 von Willebrand disease

R. Nisenbaum, P. James, J. Teitel, 2020, Research and practice in thrombosis and haemostasis.

A transcriptome analysis of basal and stimulated VWF release from endothelial cells derived from patients with type 1 VWD

Charles T. Hindmarch, P. James, N. Renwick, 2022, Blood advances.

Quantitation of Bleeding Symptoms in Children with von Willebrand Disease (VWD) or a Platelet Function Disorder: Use of a Standardized Pediatric Bleeding Score.

V. Blanchette, P. James, D. Lillicrap, 2007 .

Identifying Children with HEreditary Coagulation disorders (iCHEC): a protocol for a prospective cohort study

J. H. van der Lee, M. Suijker, V. Blanchette, 2018, BMJ Open.

The application of genetics to inherited bleeding disorders

P. James, J. Di Paola, 2010, Haemophilia : the official journal of the World Federation of Hemophilia.

Evaluation of Bleeding Symptoms in Children with An Inherited Mucocutaneous Bleeding Disorder.

V. Blanchette, P. James, T. Biss, 2009 .

Reply to comment on: Generation and optimization of the self‐administered pediatric bleeding questionnaire and its validation as a screening tool for von Willebrand disease

R. Klaassen, P. James, M. Rand, 2017, Pediatric blood & cancer.

Significant gynecological bleeding in women with low von Willebrand factor levels.

P. James, J. Di Paola, N. O'Connell, 2018, Blood advances.

Differences in the perception of blood transfusion risk between laypeople and physicians

M. Mehta, P. James, D.H. Lee, 2003, Transfusion.

Commentary: surviving sexism in bleeding disorders affecting women

P. James, M. Sholzberg, 2021, British journal of haematology.

Generation and validation of the Condensed MCMDM‐1VWD Bleeding Questionnaire for von Willebrand disease

P. James, W. Hopman, D. Lillicrap, 2008, Journal of thrombosis and haemostasis : JTH.

Novel insights into the clinical phenotype and pathophysiology underlying low VWF levels.

Kenneth L. Jones, P. James, J. Di Paola, 2017, Blood.

The prevalence of symptomatic von Willebrand disease in primary care practice

P. James, W. Hopman, D. Lillicrap, 2010, Journal of thrombosis and haemostasis : JTH.

Characterization of aberrant splicing of von Willebrand factor in von Willebrand disease: an underrecognized mechanism.

P. James, M. Poon, G. Rivard, 2016, Blood.

DIAGNOSTIC EFFICACY OF SYSTEMATIC INVESTIGATION OF NON-VON WILLEBRAND BLEEDERS: RESULTS OF A PROSPECTIVE STUDY

P. James, D. Lillicrap, M. Bowman, 2007 .

Beyond the guidelines: how we approach challenging scenarios in the diagnosis and management of von Willebrand disease.

P. James, V. Flood, Nathan T Connell, 2022, Journal of thrombosis and haemostasis : JTH.

Ringer’s lactate is compatible with saline-adenine-glucose-mannitol preserved packed red blood cells for rapid transfusion

P. James, A. Tuttle, J. Parlow, 2010, Canadian Journal of Anaesthesia-journal Canadien D Anesthesie.

Patient-centered care in von Willebrand disease: are we there yet?

J. Thachil, P. James, M. Sholzberg, 2023, Expert Review of Hematology.

Sequence Variation in Vitamin K Epoxide Reductase Gene Is Associated With Survival and Progressive Coronary Calcification in Chronic Kidney Disease

S. Booth, P. James, W. Hopman, 2014, Arteriosclerosis, thrombosis, and vascular biology.